Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials

17 Aug 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunodeficiency and Autoimmune Disorders
Share to Mycobacterium research and diagnosis
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23965219
DOI: 10.1016/j.vaccine.2013.07.051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trialsPMID 23965219Read ↗

MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB EpidemicSemantic proximity Read ↗

Advances in protein subunit vaccines against tuberculosisSemantic proximity Read ↗

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trialsSemantic proximity Read ↗

Tuberculosis vaccines — an updateSemantic proximity Read ↗

Genetic Modification of the BCG Vaccine to Overcome Its Limited Efficacy in Adults: A Specialized ReviewSemantic proximity Read ↗

BCG VaccinesSemantic proximity Read ↗

Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro–American genetic background confers optimal vaccine potentialSemantic proximity Read ↗

DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studiesSemantic proximity Read ↗

Development of an MTB39A protein-based Mycobacterium tuberculosis nanoparticle vaccine candidateSemantic proximity Read ↗

Comparative analysis of genomic characteristics and immune response between Mycobacterium tuberculosis strains cultured continuously for 25 years and H37Rv.Semantic proximity Read ↗

Developing next-generation tuberculosis vaccines based on pathogen–host interactions: Towards a holistic perspectiveSemantic proximity Read ↗

New Advances in the Development and Design of Mycobacterium tuberculosis Vaccines: Construction and Validation of Multi-Epitope Vaccines for Tuberculosis PreventionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.